<!DOCTYPE html>
<html lang="en-us"
  dir="ltr">

<head>
  <meta charset="utf-8">
<meta name="viewport" content="width=device-width">



<link rel="icon" type="image/ico" href="https://reports.muthu.co/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://reports.muthu.co/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://reports.muthu.co/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="192x192" href="https://reports.muthu.co/android-chrome-192x192.png">
<link rel="apple-touch-icon" sizes="180x180" href="https://reports.muthu.co/apple-touch-icon.png">

<meta name="description" content=""/>



<title>
    
    IOL Chemicals &amp; Pharmaceuticals Ltd - May 2025 Earnings Call Transcript Analysis | Financial Report Insights
    
</title>
<link href="/pagefind/pagefind-ui.css" rel="stylesheet">
<script src="/pagefind/pagefind-ui.js"></script>
<link rel="canonical" href="https://reports.muthu.co/posts/iol-chemicals--pharmaceuticals-ltd---may-2025-earnings-call-transcript-analysis/"/>

<meta property="og:url" content="https://reports.muthu.co/posts/iol-chemicals--pharmaceuticals-ltd---may-2025-earnings-call-transcript-analysis/">
  <meta property="og:site_name" content="Financial Report Insights">
  <meta property="og:title" content="IOL Chemicals & Pharmaceuticals Ltd - May 2025 Earnings Call Transcript Analysis">
  <meta property="og:description" content="Earnings Call Transcript Analysis Report # IOL Chemicals and Pharmaceuticals Limited - FY25 Financial Performance # Revenue # Q4 FY25: Revenue from operations grew to INR 528 crores, a 4.7% year-on-year (YoY) increase from INR 504 crores in Q4 FY24. FY25: Full-year revenue stood at INR 2,079 crores. EBITDA # Q4 FY25: Increased by 17% YoY to approximately INR 67 crores from INR 58 crores in Q4 FY24. Q4 FY25 EBITDA Margin: 12.7%, an improvement of 141 basis points YoY. FY25: EBITDA stood at INR 225 crores. FY25 EBITDA Margin: Approximately 11%. Profit After Tax (PAT) # Q4 FY25: Grew by 12% YoY to INR 31.6 crores from INR 28 crores in Q4 FY24. Q4 FY25 PAT Margin: 5.9%, an increase of 43 basis points YoY. FY25: PAT stood at INR 101 crores. FY25 PAT Margin: 4.8%. Note: PAT was impacted by higher depreciation charges from recent capital investments. Cash PAT # Q4 FY25: Stood at INR 56.4 crores, an increase of about 15% from INR 49.2 crores in Q4 FY24. FY25: Cash PAT was INR 185 crores. Debt # Net debt to equity ratio stood at 0.09 at the end of FY25 due to working capital borrowings. Download Transcript">
  <meta property="og:locale" content="en_us">
  <meta property="og:type" content="article">
    <meta property="article:section" content="posts">
    <meta property="article:published_time" content="2025-05-27T14:47:18+00:00">
    <meta property="article:modified_time" content="2025-05-27T14:47:18+00:00">
    <meta property="article:tag" content="IOL Chemicals and Pharmaceuticals Ltd.">
    <meta property="article:tag" content="IOLCP">
    <meta property="article:tag" content="API / Generic Pharmaceuticals">
    <meta property="article:tag" content="Healthcare">
    <meta property="article:tag" content="Small Cap">
    <meta property="article:tag" content="Earnings Call">













<link rel="stylesheet" href="/assets/combined.min.722a154090e948dfc0b4cf97263194700c53c73fc095c249b60a5c9caddbbf84.css" media="all">




      <script async src="https://www.googletagmanager.com/gtag/js?id=G-T7PH4WNH24"></script>
      <script>
        var doNotTrack = false;
        if ( false ) {
          var dnt = (navigator.doNotTrack || window.doNotTrack || navigator.msDoNotTrack);
          var doNotTrack = (dnt == "1" || dnt == "yes");
        }
        if (!doNotTrack) {
          window.dataLayer = window.dataLayer || [];
          function gtag(){dataLayer.push(arguments);}
          gtag('js', new Date());
          gtag('config', 'G-T7PH4WNH24');
        }
      </script>




<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-3609399560636561" crossorigin="anonymous"></script>
</head>







<body class="light">
  <div class="content">
    <header>
      

<div class="header">

    
    <div id="search"></div>
</div>

    </header>
    <main class="main">
      





<div class="breadcrumbs">
    
    <a href="/">Home</a>
    <span class="breadcrumbs-separator"> > </span>
    
    <a href="/posts/">Posts</a>
    <span class="breadcrumbs-separator"> > </span>
    
    <a class="breadcrumbs-current" href="/posts/iol-chemicals--pharmaceuticals-ltd---may-2025-earnings-call-transcript-analysis/">IOL Chemicals &amp; Pharmaceuticals Ltd - May 2025 Earnings Call Transcript Analysis</a>
</div>



<div >

  <div class="single-intro-container">

    

    <h1 class="single-title" data-pagefind-body>IOL Chemicals &amp; Pharmaceuticals Ltd - May 2025 Earnings Call Transcript Analysis</h1>
    

    

    <p class="single-readtime">
      
      
      
      <time datetime="2025-05-27T14:47:18&#43;00:00">May 27, 2025</time>
      

      
      &nbsp; · &nbsp;
      1 min read
      
    </p>

  </div>

  

  
  

  <div class="single-tags">
    
    <span>
      <a href="https://reports.muthu.co/tags/iol-chemicals-and-pharmaceuticals-ltd./">#IOL Chemicals and Pharmaceuticals Ltd.</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/iolcp/">#IOLCP</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/api-/-generic-pharmaceuticals/">#API / Generic Pharmaceuticals</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/healthcare/">#Healthcare</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/small-cap/">#Small Cap</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/earnings-call/">#Earnings Call</a>
    </span>
    
    
  </div>

  
  

  

  
  <aside class="toc">
    <p><strong>Table of contents</strong></p>
    <nav id="TableOfContents">
  <ul>
    <li><a href="#earnings-call-transcript-analysis-report">Earnings Call Transcript Analysis Report</a></li>
    <li><a href="#iol-chemicals-and-pharmaceuticals-limited---fy25-financial-performance">IOL Chemicals and Pharmaceuticals Limited - FY25 Financial Performance</a>
      <ul>
        <li><a href="#revenue">Revenue</a></li>
        <li><a href="#ebitda">EBITDA</a></li>
        <li><a href="#profit-after-tax-pat">Profit After Tax (PAT)</a></li>
        <li><a href="#cash-pat">Cash PAT</a></li>
        <li><a href="#debt">Debt</a></li>
      </ul>
    </li>
  </ul>
</nav>
  </aside>
  

  

  <div class="single-content">
    <h2 class="heading" id="earnings-call-transcript-analysis-report">
  Earnings Call Transcript Analysis Report
  <a class="anchor" href="#earnings-call-transcript-analysis-report">#</a>
</h2>
<h2 class="heading" id="iol-chemicals-and-pharmaceuticals-limited---fy25-financial-performance">
  IOL Chemicals and Pharmaceuticals Limited - FY25 Financial Performance
  <a class="anchor" href="#iol-chemicals-and-pharmaceuticals-limited---fy25-financial-performance">#</a>
</h2>
<h3 class="heading" id="revenue">
  Revenue
  <a class="anchor" href="#revenue">#</a>
</h3>
<ul>
<li><strong>Q4 FY25:</strong> Revenue from operations grew to INR 528 crores, a 4.7% year-on-year (YoY) increase from INR 504 crores in Q4 FY24.</li>
<li><strong>FY25:</strong> Full-year revenue stood at INR 2,079 crores.</li>
</ul>
<h3 class="heading" id="ebitda">
  EBITDA
  <a class="anchor" href="#ebitda">#</a>
</h3>
<ul>
<li><strong>Q4 FY25:</strong> Increased by 17% YoY to approximately INR 67 crores from INR 58 crores in Q4 FY24.</li>
<li><strong>Q4 FY25 EBITDA Margin:</strong> 12.7%, an improvement of 141 basis points YoY.</li>
<li><strong>FY25:</strong> EBITDA stood at INR 225 crores.</li>
<li><strong>FY25 EBITDA Margin:</strong> Approximately 11%.</li>
</ul>
<h3 class="heading" id="profit-after-tax-pat">
  Profit After Tax (PAT)
  <a class="anchor" href="#profit-after-tax-pat">#</a>
</h3>
<ul>
<li><strong>Q4 FY25:</strong> Grew by 12% YoY to INR 31.6 crores from INR 28 crores in Q4 FY24.</li>
<li><strong>Q4 FY25 PAT Margin:</strong> 5.9%, an increase of 43 basis points YoY.</li>
<li><strong>FY25:</strong> PAT stood at INR 101 crores.</li>
<li><strong>FY25 PAT Margin:</strong> 4.8%.</li>
<li><strong>Note:</strong> PAT was impacted by higher depreciation charges from recent capital investments.</li>
</ul>
<h3 class="heading" id="cash-pat">
  Cash PAT
  <a class="anchor" href="#cash-pat">#</a>
</h3>
<ul>
<li><strong>Q4 FY25:</strong> Stood at INR 56.4 crores, an increase of about 15% from INR 49.2 crores in Q4 FY24.</li>
<li><strong>FY25:</strong> Cash PAT was INR 185 crores.</li>
</ul>
<h3 class="heading" id="debt">
  Debt
  <a class="anchor" href="#debt">#</a>
</h3>
<ul>
<li>Net debt to equity ratio stood at 0.09 at the end of FY25 due to working capital borrowings.</li>
</ul>



<div class="button-container">    
    <a href="https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=882c5ebc-c90d-4d32-8c26-c8fb487750d1.pdf" target="_blank" class="report-button">
      <i class="fas fa-file-pdf"></i> Download Transcript
    </a>
</div>
    



    
  </div>

  


  

  
  

<div class="single-pagination">
    <hr />

    <div class="flex">

        <div class="single-pagination-prev">
            
            <div class="single-pagination-container-prev">
                <div class="single-pagination-text">←</div>
                <div class="single-pagination-text">
                    <a href="/posts/solar-industries-india-ltd---may-2025-earnings-call-transcript-analysis/">
                        Solar Industries India Ltd - May 2025 Earnings Call Transcript Analysis
                    </a>
                </div>
            </div>
            
        </div>

        <div class="single-pagination-next">
            
            <div class="single-pagination-container-next">
                <div class="single-pagination-text">
                    <a href="/posts/pearl-global-industries-ltd---may-2025-earnings-call-transcript-analysis/">
                        Pearl Global Industries Ltd - May 2025 Earnings Call Transcript Analysis
                    </a>
                </div>
                <div class="single-pagination-text">→</div>
            </div>
            
        </div>

    </div>

    <hr />
</div>



  <div id="disqus_thread"></div>
<script>
    

    

    (function() { 
    var d = document, s = d.createElement('script');
    s.src = 'https://muthuai.disqus.com/embed.js';
    s.setAttribute('data-timestamp', +new Date());
    (d.head || d.body).appendChild(s);
    })();
</script>
<noscript>Please enable JavaScript to view the <a href="https://disqus.com/?ref_noscript">comments powered by Disqus.</a></noscript>
  

  

  
  <div class="back-to-top">
    <a href="#top">
      back to top
    </a>
  </div>
  

</div>


    </main>
  </div>

  <footer>
    

    
    
    
    <p>Made with ♥ in India</p>
    


  </footer>

  

</body>

<script>

  function isAuto() {
    return document.body.classList.contains("auto");
  }

  function setTheme() {
    if (!isAuto()) {
      return
    }

    document.body.classList.remove("auto");
    let cls = "light";
    if (window.matchMedia && window.matchMedia('(prefers-color-scheme: dark)').matches) {
      cls = "dark";
    }

    document.body.classList.add(cls);
  }

  function invertBody() {
    document.body.classList.toggle("dark");
    document.body.classList.toggle("light");
  }

  if (isAuto()) {
    window.matchMedia('(prefers-color-scheme: dark)').addListener(invertBody);
  }

  setTheme();

</script>
<script>
    window.addEventListener('DOMContentLoaded', (event) => {
        new PagefindUI({ element: "#search", showSubResults: false, showImages: false });
    });
</script>
<script defer src="/js/copy-code.js"></script>
</html>